Cargando…

High Throughput Viability Assay for Microbiology

Counting viable cells is a universal practice in microbiology. The colony forming unit (CFU) assay has remained the gold standard to measure viability across disciplines; however, it is time-intensive and resource-consuming. Herein, we describe the Geometric Viability Assay (GVA) that replicates CFU...

Descripción completa

Detalles Bibliográficos
Autores principales: Meyer, Christian T., Lynch, Grace K., Stamo, Dana F., Miller, Eugene J., Chatterjee, Anushree, Kralj, Joel M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881960/
https://www.ncbi.nlm.nih.gov/pubmed/36712102
http://dx.doi.org/10.1101/2023.01.04.522767
_version_ 1784879214844968960
author Meyer, Christian T.
Lynch, Grace K.
Stamo, Dana F.
Miller, Eugene J.
Chatterjee, Anushree
Kralj, Joel M.
author_facet Meyer, Christian T.
Lynch, Grace K.
Stamo, Dana F.
Miller, Eugene J.
Chatterjee, Anushree
Kralj, Joel M.
author_sort Meyer, Christian T.
collection PubMed
description Counting viable cells is a universal practice in microbiology. The colony forming unit (CFU) assay has remained the gold standard to measure viability across disciplines; however, it is time-intensive and resource-consuming. Herein, we describe the Geometric Viability Assay (GVA) that replicates CFU measurements over 6-orders of magnitude while reducing over 10-fold the time and consumables. GVA computes a sample’s viable cell count based on the distribution of embedded colonies growing inside a pipette tip. GVA is compatible with gram-positive and -negative planktonic bacteria, biofilms, and yeast. Laborious CFU experiments such as checkerboard assays, treatment time-courses, and drug screens against slow-growing cells are simplified by GVA. We therefore screened a drug library against exponential and stationary phase E. coli leading to the discovery of the ROS-mediated, bactericidal mechanism of diphenyliodonium. The ease and low cost of GVA evinces it can accelerate existing viability assays and enable measurements at previously impractical scales.
format Online
Article
Text
id pubmed-9881960
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-98819602023-01-28 High Throughput Viability Assay for Microbiology Meyer, Christian T. Lynch, Grace K. Stamo, Dana F. Miller, Eugene J. Chatterjee, Anushree Kralj, Joel M. bioRxiv Article Counting viable cells is a universal practice in microbiology. The colony forming unit (CFU) assay has remained the gold standard to measure viability across disciplines; however, it is time-intensive and resource-consuming. Herein, we describe the Geometric Viability Assay (GVA) that replicates CFU measurements over 6-orders of magnitude while reducing over 10-fold the time and consumables. GVA computes a sample’s viable cell count based on the distribution of embedded colonies growing inside a pipette tip. GVA is compatible with gram-positive and -negative planktonic bacteria, biofilms, and yeast. Laborious CFU experiments such as checkerboard assays, treatment time-courses, and drug screens against slow-growing cells are simplified by GVA. We therefore screened a drug library against exponential and stationary phase E. coli leading to the discovery of the ROS-mediated, bactericidal mechanism of diphenyliodonium. The ease and low cost of GVA evinces it can accelerate existing viability assays and enable measurements at previously impractical scales. Cold Spring Harbor Laboratory 2023-01-04 /pmc/articles/PMC9881960/ /pubmed/36712102 http://dx.doi.org/10.1101/2023.01.04.522767 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.
spellingShingle Article
Meyer, Christian T.
Lynch, Grace K.
Stamo, Dana F.
Miller, Eugene J.
Chatterjee, Anushree
Kralj, Joel M.
High Throughput Viability Assay for Microbiology
title High Throughput Viability Assay for Microbiology
title_full High Throughput Viability Assay for Microbiology
title_fullStr High Throughput Viability Assay for Microbiology
title_full_unstemmed High Throughput Viability Assay for Microbiology
title_short High Throughput Viability Assay for Microbiology
title_sort high throughput viability assay for microbiology
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881960/
https://www.ncbi.nlm.nih.gov/pubmed/36712102
http://dx.doi.org/10.1101/2023.01.04.522767
work_keys_str_mv AT meyerchristiant highthroughputviabilityassayformicrobiology
AT lynchgracek highthroughputviabilityassayformicrobiology
AT stamodanaf highthroughputviabilityassayformicrobiology
AT millereugenej highthroughputviabilityassayformicrobiology
AT chatterjeeanushree highthroughputviabilityassayformicrobiology
AT kraljjoelm highthroughputviabilityassayformicrobiology